Obesity kills
The pen versions of GLP-1s are delivered via subcutaneous injections meaning they are injected into the fatty tissue layer just below the skin, typically in the abdomen, thigh, or upper arm
Specific forms of cancer are seen at a higher incidence and are associated with poorer survival rate in obese patients, including colorectal, breast, kidney, esophageal adenocarcinoma, endometrial and gallbladder cancer , [12] , [13]
Future randomized, prospective studies are warranted to confirm these findings and optimize treatment strategies
AN ONGOING EXPERIMENT The number of patients with cancer presenting at diagnosis with a preexisting GLP-1RAs prescription is rapidly increasing, along with the proportion of the total adult population using these agents
How much will GLP-1s cost under the Bridge